Summary
At the 8th China International Import Expo on 9 November 2026, New Zealand's a2 Milk Company and China State Farms Holdings Shanghai Co. , Ltd. launched three new infant formula products for the Chinese market: a2 Zhi Chu Qi Run, a2 Zhi Chu Zhi Chun, and the new-generation a2 Zi Bai Jin series.
The new-generation a2 Zi Bai Jin series features top-tier DHA content, 8x lutein, and three major human milk oligosaccharide (HMO)-related formulations, focusing on absorption, eye and brain development nutrition, and self-protection. The a2 Zhi Chu family expanded for the first time: a2 Zhi Chu Qi Run is a2's first dual-patent product, exploring formulation innovation around three 'maternal-source identical' nutritional dimensions—A2 protein, lipids, and oligosaccharides; a2 Zhi Chu Zhi Chun is a2's first organic A2 protein formula, sourced from New Zealand organic grass-fed farms and holding dual organic certification from China and New Zealand. David Bortolussi, Managing Director and CEO of a2 Milk Company, told Blue Whale News that the Chinese market has always been an important part of a2 Milk Company's global development strategy, and infant formula is one of its core categories for long-term development in China.
The company has always focused on A2 protein research and product development, continuously translating scientific accumulation into product innovation. In the future, it will continue to enrich product choices around the evolving needs of Chinese families and drive the brand's continued development in nutritional products across all life stages. At this year's CIIE, Theland New Cloud adopted the theme 'Nine Years of Full Attendance, CIIE Innovation' and debuted a silver economy product group including colostrum milk powder with triple hardcore self-protection, A2 β-casein 4.0 grass-fed fresh milk powder, and probiotic milk powder for middle-aged and elderly consumers, achieving an industrial upgrade from providing a good glass of milk to providing a complete nutritional health solution, creating new demand with new supply and boosting consumption.
Commentary
a2 Milk Company's launch of three new infant formula products at the CIIE, including its first organic A2 formula and a dual-patent product, shows it is moving from a single A2 protein advantage to multi-dimensional nutritional combinations to counter increasingly intense competition in China's infant formula market. China's infant formula market is worth about RMB 200 billion, but declining birth rates have intensified competition for existing share, with leading brands ramping up investment in segments such as HMO and organic. With its New Zealand milk source endorsement and research investment, a2 is well positioned to maintain share in the premium market, but it should note the rapid progress of Chinese domestic brands such as Feihe and Yili in channel penetration and formulation innovation.
For NZ SMEs, a2's moves confirm continued Chinese demand for high-value dairy products, but barriers to entry have risen significantly. Smaller dairy firms could consider differentiated opportunities in incremental areas such as adult nutrition and the silver economy, such as Theland New Cloud's probiotic milk powder for middle-aged and elderly consumers. China's population aged 60 and over exceeds 300 million, and the silver nutrition market is growing at more than 15 percent annually.
New Zealand companies can leverage natural advantages such as grass-fed and organic to develop customised products for China's ageing needs.
Keywords: a2 Milk Company, CIIE, new infant formula products, A2 protein, a2 Zhi Chu Qi Run, a2 Zhi Chu Zhi Chun, a2 Zi Bai Jin, Theland New Cloud, silver economy, China State Farms Holdings Shanghai Co., Ltd.
Photo by TheDigitalArtist on Pixabay
Source: Daily Online
Disclaimer: This article is compiled from publicly available sources for general information only. The analysis and commentary are editorial opinions. MiDeer Observer does not guarantee the accuracy or completeness of the information provided. Readers should seek independent professional advice before relying on this content, or contact us for more information.






